D86.82
Multiple cranial nerve palsies in sarcoidosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Multiple cranial nerve palsies in sarcoidosis refer to a condition where several nerves in the head and neck are affected by sarcoidosis, a disease characterized by the growth of tiny collections of inflammatory cells called granulomas. This condition can lead to noticeable weakness or paralysis in the affected nerves, impacting functions such as facial movements, eye movements, hearing, and swallowing. Although sarcoidosis primarily affects the lungs and lymph nodes, it can also involve the nervous system, including these specific cranial nerves, leading to complex neurological symptoms.
Causes & Symptoms
Clinical Causes: Granuloma formation due to sarcoidosis that targets the cranial nerves Inflammatory response leading to nerve compression or damage Immune system abnormalities causing nerve inflammation Spread of granulomatous inflammation from nearby tissues or structures Idiopathic factors, with underlying sarcoidosis as the primary trigger
Key Symptoms: Facial weakness or paralysis, often affecting one side of the face Difficulty swallowing or speaking due to nerve involvement Impaired eye movements or double vision Hearing loss or ringing in the ears (tinnitus) Loss of sensation or numbness in parts of the face Facial pain or discomfort Nasal congestion or sinus issues if the nerves related to nasal functions are involved Weakness or paralysis in other affected nerves, leading to a range of neurological deficits
Diagnostic & Treatment
Diagnosis Path: Diagnosing multiple cranial nerve palsies in sarcoidosis involves a combination of clinical evaluation and specialized tests. Healthcare providers may use imaging studies such as MRI scans to identify nerve inflammation or granulomas. Blood tests can help detect markers of inflammation and rule out other causes. A biopsy of affected tissue may be performed to confirm the presence of granulomas characteristic of sarcoidosis. Additional tests, such as lumbar puncture, may be conducted to analyze cerebrospinal fluid for signs of inflammation or granulomatous disease, aiding in differentiating this condition from other neurological disorders.
Treatment Protocols: Managing multiple cranial nerve palsies in sarcoidosis typically involves immunosuppressive therapies aimed at reducing inflammation and controlling disease activity. Common treatments include corticosteroids, such as prednisone, which help decrease granuloma formation and nerve inflammation. In cases where corticosteroids are insufficient, other immunosuppressive drugs like methotrexate or azathioprine may be employed. Symptomatic treatments, including physical therapy, speech therapy, and eye care, can assist in restoring function and preventing complications. Regular monitoring of disease progression and adjustment of therapy are crucial components of management. While treatment can often improve symptoms, some nerve damage may be permanent if intervention is delayed or if the disease is severe.
Clinical Advice & FAQs
Billing Guidance
Is D86.82 a billable ICD-10 code?
Yes, D86.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D86.82?
Clinical documentation must specify the nature of Multiple cranial nerve palsies in sarcoidosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference